JP2013524792A5 - - Google Patents

Download PDF

Info

Publication number
JP2013524792A5
JP2013524792A5 JP2013505367A JP2013505367A JP2013524792A5 JP 2013524792 A5 JP2013524792 A5 JP 2013524792A5 JP 2013505367 A JP2013505367 A JP 2013505367A JP 2013505367 A JP2013505367 A JP 2013505367A JP 2013524792 A5 JP2013524792 A5 JP 2013524792A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
absent
nucleotides
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013505367A
Other languages
English (en)
Japanese (ja)
Other versions
JP5941904B2 (ja
JP2013524792A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/002068 external-priority patent/WO2011131371A1/en
Publication of JP2013524792A publication Critical patent/JP2013524792A/ja
Publication of JP2013524792A5 publication Critical patent/JP2013524792A5/ja
Application granted granted Critical
Publication of JP5941904B2 publication Critical patent/JP5941904B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013505367A 2010-04-21 2011-04-21 脂質に結合する核酸 Expired - Fee Related JP5941904B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10004253 2010-04-21
EP10004253.0 2010-04-21
EP11000117.9 2011-01-10
EP11000117 2011-01-10
PCT/EP2011/002068 WO2011131371A1 (en) 2010-04-21 2011-04-21 Lipid binding nucleic acids

Publications (3)

Publication Number Publication Date
JP2013524792A JP2013524792A (ja) 2013-06-20
JP2013524792A5 true JP2013524792A5 (enExample) 2014-06-05
JP5941904B2 JP5941904B2 (ja) 2016-06-29

Family

ID=44201395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013505367A Expired - Fee Related JP5941904B2 (ja) 2010-04-21 2011-04-21 脂質に結合する核酸

Country Status (5)

Country Link
US (1) US8871920B2 (enExample)
EP (1) EP2561079A1 (enExample)
JP (1) JP5941904B2 (enExample)
CN (1) CN102906265B (enExample)
WO (1) WO2011131371A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012095303A1 (en) * 2011-01-10 2012-07-19 Noxxon Pharma Ag Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
EP2802659A1 (en) 2012-01-10 2014-11-19 Noxxon Pharma AG Nucleic acids specifically binding cgrp
PT2802660T (pt) 2012-01-10 2020-04-21 Aptarion Biotech Ag Novos ácidos nucleicos que se ligam a c5a
AU2017221441A1 (en) * 2016-02-17 2018-10-04 Children's Medical Center Corporation FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders
EP3264092A1 (en) 2016-07-01 2018-01-03 Centogene AG Use of lyso-gb1 as druggable target
MX2020012225A (es) 2018-05-17 2021-01-29 Procter & Gamble Sistemas y metodos para el analisis de la cobertura del cabello.
JP2021523454A (ja) 2018-05-17 2021-09-02 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 毛髪分析のためのシステム及び方法
WO2020005326A1 (en) 2018-06-29 2020-01-02 The Procter & Gamble Company Aptamers for personal care applications
CN112384622A (zh) * 2018-06-29 2021-02-19 宝洁公司 用于毛发护理应用的适配体
CN109402127B (zh) * 2018-09-29 2021-12-10 复旦大学附属眼耳鼻喉科医院 一组与结缔组织生长因子特异性结合的高亲和力核酸适配体及其应用
EP3956451A1 (en) 2019-04-16 2022-02-23 The Procter & Gamble Company Aptamers for odor control applications
AU2020313090A1 (en) * 2019-07-17 2021-12-23 Noxopharm Limited Immuno-oncology therapy using isoflavone compounds
US12039732B2 (en) 2021-04-14 2024-07-16 The Procter & Gamble Company Digital imaging and learning systems and methods for analyzing pixel data of a scalp region of a users scalp to generate one or more user-specific scalp classifications

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011020A (en) 1990-06-11 2000-01-04 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand complexes
US6225063B1 (en) 1998-05-22 2001-05-01 University Technology Corporation RNA channels in biological membranes
US6395029B1 (en) 1999-01-19 2002-05-28 The Children's Hospital Of Philadelphia Sustained delivery of polyionic bioactive agents
US6652886B2 (en) 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
EP1306382A1 (de) 2001-10-26 2003-05-02 Noxxon Pharma AG Modifizierte L-Nukleinsäure
EP1438321B1 (de) 2001-10-26 2010-05-26 Noxxon Pharma AG Modifizierte l-nukleinsäure
WO2003070823A2 (en) 2002-02-20 2003-08-28 The General Hospital Corporation Conjugates comprising a biodegradable polymer and uses therefor
AU2004230927B9 (en) 2003-04-13 2011-12-01 Enzon Pharmaceuticals, Inc. Polymeric oligonucleotide prodrugs
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
KR101189555B1 (ko) 2004-02-09 2012-10-16 주프라몰 파렌테랄 콜로이츠 게엠베하 폴리사카라이드 및 폴리뉴클레오티드로부터 접합체를제조하는 방법
CA2786794C (en) 2004-03-23 2017-09-12 Complex Biosystems Gmbh Aromatic polymeric cascade prodrug linker reagent
EP1807092B1 (en) 2004-11-05 2016-09-07 The Children's Hospital of Philadelphia Biodegradable linkers for molecular therapies
MX2007013760A (es) 2005-05-04 2008-01-28 Noxxon Pharma Ag Uso novedoso de spiegelmers.
US20090074720A1 (en) * 2005-10-28 2009-03-19 Sabbadini Roger A Methods for decreasing immune response and treating immune conditions
US7862812B2 (en) * 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
WO2008034122A2 (en) 2006-09-15 2008-03-20 Enzon Pharmaceuticals, Inc. Hindered ester-based biodegradable linkers for oligonucleotide delivery
WO2008052774A2 (en) 2006-10-31 2008-05-08 Noxxon Pharma Ag Methods for detection of a single- or double-stranded nucleic acid molecule

Similar Documents

Publication Publication Date Title
Martino et al. Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance
Ripke et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia
JP2014533098A5 (enExample)
JP2023153949A (ja) ヒトｅｚｈ２の阻害剤、およびその使用方法
JP2009543567A5 (enExample)
JP2012525124A5 (enExample)
JP2015509705A5 (enExample)
JPWO2013073602A1 (ja) 標的タンパク質に結合する核酸断片
JP2013540423A5 (enExample)
ES2629183T3 (es) Aptámeros para diagnóstico de Clostridium difficile
RU2016136716A (ru) Способы диагностики и лечения воспалительного заболевания кишечника
RU2008136907A (ru) Нуклеиновые кислоты, связывающиеся с мср-1
Gupta et al. Impact of diet and host genetics on the murine intestinal mycobiome
DK3277835T3 (en) GENETIC PREDICTORS OF A REACTION ON TREATMENT WITH CRHR1 ANTAGONISTS
JP2015506174A5 (enExample)
JP2009526532A5 (enExample)
RU2014132706A (ru) Нуклеиновые кислоты, специфически связывающие cgrp
JP2014504865A5 (enExample)
Zhou et al. Fast and sensitive multivalent spatial pattern-recognition for circular RNA detection
CN104450727A (zh) X-连锁低磷酸盐血症性佝偻病的致病基因及其编码蛋白质和应用
JP7118046B2 (ja) オピオイド薬の治療有効性を予測するためのｍｉｃｒｏＲＮＡバイオマーカー
Chen et al. Functional characterization and clinical implication of a novel epidemic carbapenem-resistant Acinetobacter baumannii genetic marker
CN101892297B (zh) 高血压易感基因单核苷酸多态性位点的检测方法及其试剂盒
Sacharczuk et al. A polymorphism in exon 2 of the δ-opioid receptor affects nociception in response to specific agonists and antagonists in mice selectively bred for high and low analgesia
Zhang et al. Genotypic and phenotypic characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy from China